I like that some centres will be in the USA.
Maybe the USA patients will show significant improvement in PMD and the rest of the world patients won't and all regulators will be happy.
Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-6
-
- There are more pages in this discussion • 163 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.763M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17222 | 9.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 6250 | 2 |
View Market Depth
| Last trade - 16.12pm 01/11/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable